P
Paul Warrener
Researcher at MedImmune
Publications - 11
Citations - 6301
Paul Warrener is an academic researcher from MedImmune. The author has contributed to research in topics: Pseudomonas aeruginosa & Antibacterial agent. The author has an hindex of 8, co-authored 11 publications receiving 5876 citations. Previous affiliations of Paul Warrener include Novartis.
Papers
More filters
Journal ArticleDOI
Complete genome sequence of Pseudomonas aeruginosa PAO1, an opportunistic pathogen.
Charles K. Stover,X. Q. Pham,A. L. Erwin,S. D. Mizoguchi,Paul Warrener,Mark J. Hickey,Fiona S. L. Brinkman,W. O. Hufnagle,D. J. Kowalik,Lagrou Mj,R. L. Garber,L. Goltry,E. Tolentino,S. Westbrock-Wadman,Ying Yuan,L. L. Brody,S. N. Coulter,K. R. Folger,Arnold Kas,K. Larbig,R. Lim,Kelly D. Smith,David H. Spencer,Gane Ka-Shu Wong,Z. Wu,Ian T. Paulsen,Ian T. Paulsen,Jonathan Reizer,Milton H. Saier,Robert E. W. Hancock,Stephen Lory,Maynard V. Olson +31 more
TL;DR: It is proposed that the size and complexity of the P. aeruginosa genome reflect an evolutionary adaptation permitting it to thrive in diverse environments and resist the effects of a variety of antimicrobial substances.
Journal ArticleDOI
A small-molecule nitroimidazopyran drug candidate for the treatment of tuberculosis.
C. Kendall Stover,Paul Warrener,Donald R. VanDevanter,David R. Sherman,Taraq M. Arain,Michael H. Langhorne,Scott Anderson,J. Andrew Towell,Ying Yuan,David N. McMurray,Barry N. Kreiswirth,Clifton E. Barry,William R. Baker +12 more
TL;DR: It is concluded that nitroimidazopyrans offer the practical qualities of a small molecule with the potential for the treatment of tuberculosis and bactericidal activity against both replicating and static M. tuberculosis.
Journal ArticleDOI
Detection and analysis of diverse herpesviral species by consensus primer PCR.
Donald R. VanDevanter,Paul Warrener,Lindsely Bennett,Emily R. Schultz,Silvija N. Coulter,Richard L. Garber,Timothy M. Rose +6 more
TL;DR: Estimation of template dilution studies in the presence of human carrier DNA demonstrated that six human herpesviruses could be detected at levels at or below 100 genome equivalents per 100 ng of carrier DNA, suggesting that consensus primer PCR targeted to herpesviral DNA polymerase may prove to be useful in the detection and identification of known herpesvirus in clinical samples and the initial characterization of new herpesViral genomes.
Journal ArticleDOI
Characterization of a Pseudomonas aeruginosa efflux pump contributing to aminoglycoside impermeability
Shannon Westbrock-Wadman,David R. Sherman,Mark J. Hickey,Silvija N. Coulter,Ya Qi Zhu,Paul Warrener,Lisa Nguyen,Ribhi Shawar,Kim R. Folger,C. Kendall Stover +9 more
TL;DR: Although it is unlikely that hyperexpression of AmrAB is the sole mechanism conferring the impermeability phenotype, it is believed that the Amr efflux system can contribute to a complex interaction of molecular events resulting in the aminoglycoside impermeable-type resistance phenotype.
Journal ArticleDOI
Mutations in the cueA gene encoding a copper homeostasis P-type ATPase reduce the pathogenicity of Pseudomonas aeruginosa in mice.
TL;DR: Complementation of the cueA mutation restored in vitro tolerance to copper and virulence in a systemic model of infection to near wild-type levels and suggests the P. aeruginosa CueA protein may be important in maintaining copper homeostasis both in vitro and in vivo.